Drugs News and Research

RSS

PharmSource ranks Patheon as top global contract development and manufacturing organization

Patheon, a global provider of drug development and manufacturing services to the international pharmaceutical industry announced today that it has been ranked as a top global contract development and manufacturing organization. PharmSource(R), a respected independent pharmaceutical research organization, recently published a study looking at the number of FDA new drug approvals (NDAs and BLAs) which were outsourced by sponsor companies and subsequently launched.

15 Jul 2010

Activities of TAT fully consolidated into Geron

Geron Corporation today announced that the activities of TA Therapeutics, its joint venture with Hong Kong University of Science and Technology, are being fully consolidated into Geron.

15 Jul 2010

MEDTOX Scientific second-quarter total revenues increase 18.1% to $25.2 million

MEDTOX Scientific, Inc. today announced results for the second quarter ended June 30, 2010. MEDTOX achieved a significant increase in new clinical laboratory business for the quarter ended June 30, 2010, and laboratory drugs-of-abuse testing showed a net positive increase in revenues of 5.6% for the second quarter of 2010, compared to a decrease of 10.6% in the prior year quarter.

15 Jul 2010

New drug launches for HCV in the Philippines to increase market earned revenues to $4.5 billion by 2017

Efforts to raise disease awareness in the Philippines have increased the number of cases and patient pool available for hepatitis C treatment. Screening and detection efforts by the Red Cross as well as growing awareness in the Philippines have been largely responsible for the rise in the number of diagnosed cases. These campaigns have encouraged people, mostly from the urban areas, to opt for physical examinations that enable the detection of hepatitis C.

15 Jul 2010

Research shows behavioral economic analysis may help understand role of craving in addictions

Just-published research led by a psychologist at the University of Georgia shows that behavioral economic analysis may lead to an improved understanding of craving for alcohol and other drugs. This method of studying how craving alters the way a person values a drug is fairly new, but according to the study, it may well help assess cravings more accurately and contribute to identifying more effective ways to defeat addictions.

15 Jul 2010

New use of green fluorescent protein

Scientists are reporting discovery of a way to help proteins such as the new generation of protein-based drugs -- sometimes heralded as tomorrow's potential "miracle cures" -- get past the biochemical "Entrance Forbidden" barrier that keeps them from entering cells and doing their work. The new technique, described in the monthly journal, ACS Chemical Biology, represents a new use for an engineered form of green fluorescent protein, the topic of the 2008 Nobel Prize in Chemistry that is one of the most important research tools in biosciences.

15 Jul 2010

Scientists awarded $2.3M grant to develop new treatments for drug addiction

A pair of scientists on the Florida campus of The Scripps Research Institute has been awarded a $2.3 million grant by the National Institutes of Health to conduct research relevant to developing new treatments for drug addiction.

15 Jul 2010

UNC research to be presented at International AIDS Society conference

Dozens of UNC researchers are heading to Vienna, Austria to participate in the world's preeminent AIDS conference this week. The International AIDS Society conference brings together top scientists, advocates and government officials to discuss progress and chart a course for stemming the spread and impact of AIDS. Speakers including President Bill Clinton will address an estimated 25,000 attendees at this year's event.

15 Jul 2010

American Heart Association comments on FDA advisory committee's rosiglitazone recommendations

After two days of hearings, an advisory committee to the U.S. Food and Drug Administration (FDA) recommended that the FDA allow the type 2 diabetes drug rosiglitazone (brand name, Avandia), to stay on the market, but with most committee members suggesting that the label be revised to include increased warnings. Rosiglitazone is one in a class of drugs called thiazolidinediones (TZDs), used to treat type 2 diabetes.

15 Jul 2010

Nine new institutions receive NIH Clinical and Translational Science Awards

Nine health research centers have received funds to develop ways to reduce the time it takes for clinical research to become treatments for patients. The funds were awarded as part of the Clinical and Translational Science Awards (CTSA) program which is led by the National Center for Research Resources (NCRR), part of the National Institutes of Health.

15 Jul 2010

Pre-clinical study results of EVP-0015962 presented at AAICAD 2010

EnVivo Pharmaceuticals today announced at the Alzheimer's Association 2010 International Conference on Alzheimer's Disease results from its proprietary gamma-secretase modulator pre-clinical study. In a transgenic mouse model, EnVivo's EVP-0015962 reduced amyloid plaque buildup which is believed to be a cause of Alzheimer's disease, reversed behavioral deficits and reduced brain inflammation associated with Alzheimer's disease.

15 Jul 2010

Variations in quality of illegal Class B drug mephedrone could risk safety of users

Pharmaceutical scientists have discovered that the recently reclassified drug mephedrone varies in quality so much that users could be at risk of overdosing. Six samples were tested in the University of Sunderland's labs by Dr John Lough and his team, and although impurities levels were low, three samples revealed various particle size and crystalline form, which means that the drug is more likely to vary in its affect and safety on the user.

15 Jul 2010

GSK confirms FDA advisory committees' vote to allow Avandia to remain on the market

GlaxoSmithKline confirmed today that a joint advisory committee to the U.S. Food and Drug Administration (FDA) voted to allow Avandia to remain on the market. Committee members voted for recommendations ranging from making no changes to the current label, to revising the label with additional warnings and restrictions to withdrawal from the U.S. market.

15 Jul 2010

New HIV treatment strategy could reduce HIV-related deaths by 10M in 15 years, UNAIDS says

UNAIDS on Tuesday outlined a new strategy, called "Treatment 2.0," to simplify the provision of HIV treatment and improve global access to antiretrovirals, Reuters reports. The agency says the plan could prevent up to 10 million AIDS-related deaths by 2025 and reduce the number of new HIV infections annually by up to one million, if all people in need receive treatment, according to the news service.

15 Jul 2010

SWCRF/Emerald Foundation Global Collaborative Grant to fund critical cancer research

The leukemia stem cell-the root cause of all acute leukemias- represents a small population of cells in patients that are difficult to eliminate with standard treatments available today. Though current chemotherapy can produce temporary remission in leukemia survivors, they remain at risk of experiencing a recurrence and dying from the disease.

15 Jul 2010

CardioGenics Holdings' subsidiary signs second product agreement with Merck Chimie

CardioGenics Holdings Inc., developer of the ultra-sensitive QL Care Point-Of-Care analyzer and products for the immunoassay segment of the In-Vitro Diagnostics market, announced that the Company's subsidiary, CardioGenics Inc., has entered into an agreement with Merck Chimie S.A.S. to adopt its proprietary biological-linking technology to Merck-supplied magnetic beads designed to increase yields in antibody manufacturing.

15 Jul 2010

Florida Medicaid recipients make fewer trips to doctors; Calif. payments to health clinics in jeopardy; Texas addresses nursing shortage

Northeast Florida's Medicaid recipients are making fewer trips to the doctor for chronic illnesses since state officials outsourced the government-subsidized health insurance program to private managed care companies. But it remains unclear from the analysis performed by the Florida Agency for Health Care Administration, which oversees the state's Medicaid program, whether they're healthier for it. Medicaid reform was launched in 2006 in Duval and Broward counties to test whether HMOs could rein in the state's Medicaid spending.

15 Jul 2010

Absorption Systems' GLP facility receives full accreditation from AAALAC

Absorption Systems, a leader in testing drugs for ADMET, announced today that its GLP facility in San Diego, Calif., for preclinical testing of drugs, biologics and medical devices received full accreditation from the Association for the Assessment and Accreditation of Laboratory Animal Care International.

15 Jul 2010

Doctors reluctant to report colleagues for being impaired, incompetent

The Associated Press: "Your doctor could be drunk, addicted to drugs or outright incompetent, but other physicians may not blow the whistle. A new survey finds that many American physicians fail to report troubled colleagues to authorities, believing that someone else will take care of it, that nothing will happen if they act or that they could be targeted for retribution.

15 Jul 2010

Samsung Medical Center, Pfizer form research partnership

Samsung Medical Center and the world's leading bio-pharmaceutical company Pfizer Inc. announced that they have formed a research partnership to jointly analyze tumors from Korean patients to generate gene expression profiles and that may ultimately direct therapies and enhance clinical outcomes in the patients with liver cancer.

14 Jul 2010

Drugs News and Research

PharmSource ranks Patheon as top global contract development and manufacturing organization

Activities of TAT fully consolidated into Geron

MEDTOX Scientific second-quarter total revenues increase 18.1% to $25.2 million

New drug launches for HCV in the Philippines to increase market earned revenues to $4.5 billion by 2017

Research shows behavioral economic analysis may help understand role of craving in addictions

New use of green fluorescent protein

Scientists awarded $2.3M grant to develop new treatments for drug addiction

UNC research to be presented at International AIDS Society conference

American Heart Association comments on FDA advisory committee's rosiglitazone recommendations

Nine new institutions receive NIH Clinical and Translational Science Awards

Pre-clinical study results of EVP-0015962 presented at AAICAD 2010

Variations in quality of illegal Class B drug mephedrone could risk safety of users

GSK confirms FDA advisory committees' vote to allow Avandia to remain on the market

New HIV treatment strategy could reduce HIV-related deaths by 10M in 15 years, UNAIDS says

SWCRF/Emerald Foundation Global Collaborative Grant to fund critical cancer research

CardioGenics Holdings' subsidiary signs second product agreement with Merck Chimie

Florida Medicaid recipients make fewer trips to doctors; Calif. payments to health clinics in jeopardy; Texas addresses nursing shortage

Absorption Systems' GLP facility receives full accreditation from AAALAC

Doctors reluctant to report colleagues for being impaired, incompetent

Samsung Medical Center, Pfizer form research partnership

Drug Discovery - Second Edition eBook

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Latest News